Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Hematology

Doctor Smitha S. Krishnamurthi, MD works in the field of Hematology. She went to medical school at Perelman School of Medicine at the University of Pennsylvania. She received awards:"America's Top Doctors" and "America's Top Doctors for Cancer". Smitha S. Krishnamurthi is a published doctor and has 23 publications published. The lastest was: 'Comparative endoscopic study of primary gastric lymphoma vs. gastric carcinoma.' Smitha S. Krishnamurthi is registered with Medicare and accepts Medicare payments.

Publications

---

• A phase I study of MK-5108, an Oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refract...
• Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: ...
• The effects of Liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor recep...
• Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic Cancer: a phase 2 study.
• Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors.
• ColoRectal carcinoma: overview of clinical research and management 2011.
• Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer.
• Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced Cancers.
• Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
• Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal Cancer patients treated with cetuximab.
• Adjuvant therapy for rectal Cancer.
• Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary Cancers.
• A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction Carcinoma.
• Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
• Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
• Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid Tumors.
• A phase I study of rebeccamycin Analog in combination with oxaliplatin in patients with refractory solid tumors.
• A multicenter phase II study of "adjuvant" irinotecan following resection of coloRectal hepatic metastases.
• Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic Cancer: results of a phase II randomized, doub...
• Preoperative multimodal therapy for locally advanced non-inflammatory breast Cancer.
• Comparative endoscopic study of primary gastric lymphoma vs. gastric Carcinoma.
• The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients.

Schools

---

• University Of Pennsylvania School Of Medicine

• Hospital University Pa

• Johns Hopkins Hospital

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology
• Hematology

Accepted Insurances

---

Awards

---

• America's Top Doctors
• America's Top Doctors for Cancer

Education

---

• Johns Hopkins University
• University of Pennsylvania Health System
• Perelman School of Medicine at the University of Pennsylvania

Hospital

---

• University Hospitals Case Medical Center

Drug Facts

---

NPI NUMBER		1487670147
NPPES Provider LastName		KRISHNAMURTHI
NPPES Provider FirstName		SMITHA
NPPES Provider ZIPCode		441061716
NPPES Provider State		OH
Specialty Description		Hematology/Oncology
Total Claim Count		433.0
Distinct Opioid Count		2.0
Opioid Claim Count		49.0
Percent Opioid Claims		11.32

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1487670147
Last Name Of The Provider	KRISHNAMURTHI
First Name Of The Provider	SMITHA
View All

Similar Doctors

---

	Dr. David J. Adelstein, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mikkael A. Sekeres, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Anita Schwandt, MD
	Dr. Joseph Gibbons, MD This Doctor is OpenDoctor Recommended.
	Dr. Amy McKenney, MD This Doctor is OpenDoctor Recommended.
	Dr. Heesun Rogers, MD
	Dr. Joseph A. Bokar, MD This Doctor is OpenDoctor Recommended.
	Dr. Jaroslaw P. Maciejewski, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Shunyou Gong, MD This Doctor is OpenDoctor Recommended.
	Dr. Angela M. Collie, MD
	Yogenthiran Saunthararajah, MB BCH This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog